Physician profile
Emily Stege
NPI 1659801207
$5,905.77
in general payments reported to CMS, 2019-2025
40 companies · $1,873 in 2025
The $1,873 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $540 · 2023: $1,831 · 2024: $1,661 · 2025: $1,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,149 · Education: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,148.65 |
| Education | $216.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,386.29 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $907.66 | 2023-2025 | |
| Astellas Pharma US INC | $474.52 | 2023-2024 | Veozah |
| Lilly USA, LLC | $436.17 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $433.39 | 2022-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $301.94 | 2022-2025 | Rybelsus, Wegovy, Ozempic |
| Tersera Therapeutics LLC | $292.20 | 2024-2025 | Quzyttir |
| Corcept Therapeutics | $222.14 | 2024-2025 | Korlym |
| Exact Sciences Corporation | $166.05 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $118.03 | 2023-2025 | |
| Abbott Laboratories | $108.49 | 2025 | Freestyle Libre 3 |
| Lundbeck LLC | $96.52 | 2024-2025 | Vyepti, Rexulti |
| Amgen INC. | $92.37 | 2024-2025 | Otezla, Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $82.25 | 2023-2024 | Xarelto, Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $57.52 | 2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Stege listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.